LifeSteps Financial’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Sell
1,525
-72
-5% -$13K 0.1% 93
2026
Q1
$235K Sell
1,597
-40
-2% -$6.5K 0.15% 84
2025
Q4
$319K Buy
1,637
+40
+3% +$9.52K 0.2% 71
2025
Q3
$449K Buy
1,597
+20
+1% +$5.09K 0.29% 54
2025
Q2
$345K Hold
1,577
0.24% 65
2025
Q1
$221K Sell
1,577
-50
-3% -$8.14K 0.18% 78
2024
Q4
$271K Buy
+1,627
New +$289K 0.21% 71
2024
Q2
Sell
-658
Closed -$82.7K 305
2024
Q1
$82.7K Buy
+658
New +$75.3K 0.06% 118

Other funds holding ORCL

LifeSteps Financial's ORCL Position: Q2 2026 in Review

LifeSteps Financial reduced its Oracle (ORCL) stake by 4.5% in Q2 2026, selling an estimated $13K and leaving 1,525 shares worth $224K. The position accounts for 0.1% of the portfolio, ranked #93.

LifeSteps Financial first reported a position in ORCL in Q1 2024 and has held it in 8 quarters since. The position peaked at $449K in Q3 2025. 1,509 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • LifeSteps Financial held 1,525 shares of Oracle worth $224K as of Q2 2026.
  • LifeSteps Financial sold 72 Oracle shares in Q2 2026, an estimated $13K.
  • Oracle made up 0.1% of LifeSteps Financial's portfolio in Q2 2026, its #93 holding.
  • LifeSteps Financial first reported a position in Oracle in Q1 2024 and has held it in 8 quarters since.
  • LifeSteps Financial's Oracle position peaked at $449K in Q3 2025.
  • 1,509 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on LifeSteps Financial's 13F filing for Q2 2026, filed 17 Jul 2026.